Toluene Abuse and White Matter. A Model of Toxic Leukoencephalopathy.

Psychiatric Clinics of North America

Volumn 36, Issue 2, 2013, Pages 293-302

  Filley, Christopher M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; Inhalants; Leukoencephalopathy; Toluene; Toxic; White matter

Indexed keywords

2 BUTANONE; 2 HEXANONE; BENZENE; BUTANE; DICHLOROMETHANE; HEXANE; METHANOL; METHYL CHLORIDE; NITROUS OXIDE; PETROLEUM DERIVATIVE; PROPANE; TETRACHLOROETHYLENE; TOLUENE; TRICHLOROETHANE; TRICHLOROETHYLENE; XYLENE;

ABSTINENCE; ALZHEIMER DISEASE; AMERICAN INDIAN; ANATOMICAL CONCEPTS; ANTISOCIAL BEHAVIOR; BONE MARROW SUPPRESSION; BRAIN ATROPHY; BRAIN CORTEX; BRONCHITIS; CLINICAL FEATURE; COMA; CONFUSION; COORDINATION DISORDER; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DIZZINESS; HEADACHE; HEART ARRHYTHMIA; HIPPOCAMPUS; HISPANIC; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOPATHOLOGY; KIDNEY TUBULE ACIDOSIS; LEUKOENCEPHALOPATHY; NEUROBIOLOGY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PATIENT CARE; PHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; REVIEW; SUBSTANCE ABUSE; TERATOGENICITY; WHITE MATTER;

ATROPHY; BRAIN; DEMENTIA; HUMANS; INHALANT ABUSE; LEUKOENCEPHALOPATHIES; NERVE FIBERS, MYELINATED; PROGNOSIS; SOLVENTS; TOLUENE;

EID: 84877923699     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2013.02.008     Document Type: Review

References (50)

1. Howard M.O., Bowen S.E., Garland E.L., et al. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 2011, 6:18-31.
2. Filley C.M., Kleinschmidt-DeMasters B.K. Toxic leukoencephalopathy. N Engl J Med 2001, 345:425-432.
3. Miller A.K., Alston R.L., Corsellis J.A. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyzer. Neuropathol Appl Neurobiol 1980, 6:119-132.
4. Saver J.L. Time is brain-quantified. Stroke 2006, 37:263-266.
5. Nolte J. The human brain 2002, Mosby, St Louis (MO). 5th edition.
6. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 1998, 50:1535-1540.
7. Aralasmak A., Ulmer J.L., Kocak M., et al. Association, commissural, and projection pathways and their functional deficit reported in literature. J Comput Assist Tomogr 2006, 30:695-715.
8. Filley C.M. White matter: organization and functional relevance. Neuropsychol Rev 2010, 20:158-173.
9. Schmahmann J.D., Pandya D.N. Fiber pathways of the brain 2006, Oxford University Press, New York.
10. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian nervous system. Physiol Rev 2001, 81:871-927.
11. Bennaroch E.F. Oligodendrocytes. Susceptibility to injury and involvement in neurologic disease. Neurology 2009, 72:1779-1785.
12. Turken A.U., Whitfield-Gabrieli S., Bammer R., et al. Cognitive speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage 2008, 42:1032-1044.
13. Kochunov P., Coyle T., Lancaster J., et al. Processing speed is correlated with cerebral health markers in the frontal lobes quantified by neuroimaging. Neuroimage 2010, 49:1190-1199.
14. Mesulam M.M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990, 28:597-613.
15. Filley C.M. White matter and behavioral neurology. Ann N Y Acad Sci 2005, 1064:162-183.
16. Brouette T., Anton R. Clinical review of inhalants. Am J Addict 2001, 10:79-94.
17. Grabski D.A. Toluene sniffing producing cerebellar degeneration. Am J Psychiatry 1961, 118:461-462.
18. Hormes J.T., Filley C.M., Rosenberg N.L. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986, 36:698-702.
19. Rosenberg N.L., Spitz M.C., Filley C.M., et al. Central nervous system effects of chronic toluene abuse-clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988, 10:489-495.
20. Yamanouchi N., Okada S., Kodama K., et al. White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995, 16:1643-1649.
21. Aydin K., Sencer S., Demir T., et al. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 2002, 23:1173-1179.
22. Filley C.M., Heaton R.K., Rosenberg N.L. White matter dementia in chronic toluene abuse. Neurology 1990, 40:532-534.
23. Rosenberg N.K., Kleinschmidt-DeMasters B.K., Davis K.A., et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988, 23:611-614.
24. Kornfeld M., Moser A.B., Moser H.W., et al. Solvent vapor abuse leukoencephalopathy. Comparison to adrenoleukodystrophy. J Neuropathol Exp Neurol 1994, 53:389-398.
25. Marulanda N., Colegial C. Neurotoxicity of solvents in brain of glue abusers. Environ Toxicol Pharmacol 2005, 19:671-675.
26. Filley C.M., Halliday W., Kleinschmidt-DeMasters B.K. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004, 63:1-12.
27. Rosenberg N.L., Grigsby J., Dreisbach J., et al. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 2002, 40:21-34.
28. Yücel M., Takagi M., Walterfang M., et al. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 2008, 32:910-926.
29. Al-Hajri Z., Del Bigio M.R. Brain damage in a large cohort of solvent abusers. Acta Neuropathol 2010, 119:435-445.
30. Filley C.M., Franklin G.M., Heaton R.K., et al. White matter dementia. Clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol 1988, 1:239-254.
31. Filley C.M. The behvavioral neurology of white matter 2012, Oxford University Press, New York. 2nd edition.
32. Schoenemann P.T., Sheehan M.J., Glotzer L.D. Prefrontal white matter volume is disproportionately larger in humans than in other primates. Nat Neurosci 2005, 8:242-252.
33. Parvizi J. Corticocentric myopia: old bias in new cognitive sciences. Trends Cogn Sci 2009, 13:354-359.
34. Takagi M., Lubman D.I., Yücel M. Solvent-induced leukoencephalopathy: a disorder of adolescence?. Subst Use Misuse 2011, 46(Suppl 1):95-98.
35. Qureshi S.U., Blanchette A.R., Jawaid A., et al. Reversible leukoencephalopathy due to chronic unintentional exposure to toluene. Can J Neurol Sci 2009, 36:388-389.
36. Lubman D.I., Yücel M., Lawrence A.J. Inhalant abuse among adolescents: neurobiological considerations. Br J Pharmacol 2008, 154:316-326.
37. Sakai J.T., Mikulich-Gilbertson S.K., Crowley T.J. Adolescent inhalant use among male patients in treatment for substance and behavior problems: two-year outcome. Am J Drug Alcohol Abuse 2006, 32:29-40.
38. Konghom S., Verachai V., Srisurapanont M., et al. Treatment for inhalant dependence and abuse. Cochrane Database Syst Rev 2010, (12). CD007537.
39. Aydin K., Sencer S., Ogel K., et al. Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging 2003, 21:777-785.
40. Yücel M., Zalesky A., Takagi M.J., et al. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study. J Psychiatry Neurosci 2010, 35:409-412.
41. Gospe S.M., Calaban M.J. Central nervous system distribution of inhaled toluene. Fundam Appl Toxicol 1988, 11:540-545.
42. Ameno K., Kiriu T., Fuke C., et al. Regional brain distribution of toluene in rats and in a human autopsy. Arch Toxicol 1992, 66:153-156.
43. Duncan J.R., Dick A.L., Egan G., et al. Adolescent toluene inhalation in rats affects white matter maturation with the potential for recovery following abstinence. PLoS One 2012, 7:e44790.
44. Schiffer W.K., Lee D.E., Alexoff D.L., et al. Metabolic correlates of toluene abuse: decline and recovery of function in adolescent animals. Psychopharmacology 2006, 186:159-167.
45. Harris J.B., Blain P.G. Neurotoxicology: what the neurologist needs to know. J Neurol Neurosurg Psychiatry 2004, 75(Suppl 3):iii29-iii34.
46. Schaumburg H.H., Albers J.W. Pseudoneurotoxic disease. Neurology 2005, 62:22-26.
47. Ridgway P., Nixon T.E., Leach J.P. Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology. Food Chem Toxicol 2003, 41:153-187.
48. Kumar A., Cook I.A. White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci 2002, 24:255-261.
49. Bartzokis G. Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc Psychiatry 2005, 29:55-96.
50. Fields R.D. White matter in learning, cognition, and psychiatric disorders. Trends Neurosci 2008, 31:361-370.